Stay updated on BIVV009 Safety & Activity in Complement Disorders Clinical Trial
Sign up to get notified when there's something new on the BIVV009 Safety & Activity in Complement Disorders Clinical Trial page.

Latest updates to the BIVV009 Safety & Activity in Complement Disorders Clinical Trial page
- Check4 days agoChange DetectedMinor site updates were applied: a new Revision: v3.4.2 banner was added and the earlier Revision: v3.4.1 notice was removed, along with deletion of a government funding/operating status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check11 days agoChange DetectedA new government funding notice banner was added, informing users of possible delays and that the NIH Clinical Center is open. The page revision version was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check18 days agoChange DetectedAdded a glossary display option and included a 'Last Update Submitted that Met QC Criteria' label in Study Record Dates. Footer notes now show 'No FEAR Act Data' and 'Revision: v3.4.0', replacing the previous wording.SummaryDifference0.2%

- Check32 days agoChange DetectedRevision: v3.3.4 is now shown; the previous v3.3.3 label is removed. No study data or page functionality appears to be altered.SummaryDifference0.1%

- Check53 days agoChange DetectedFooter updates: revision numbers added and the HHS Vulnerability Disclosure link removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check82 days agoChange DetectedThe additions and deletions describe notes that PubMed publications are automatically filled and update the revision label from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to BIVV009 Safety & Activity in Complement Disorders Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BIVV009 Safety & Activity in Complement Disorders Clinical Trial page.